Novo Nordisk A/S Intends to Appeal Adverse Ruling in Prandin® (repaglinide) Patent Case

BAGSVæRD, DENMARK--(Marketwire - January 19, 2011) -

Company Announcement no 2 2011: http://hugin.info/2013/R/1480941/416315.pdf

This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that: (i) the releases contained herein are protected by copyright and other applicable laws; and (ii) they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Novo Nordisk A/S via Thomson Reuters ONE

[HUG#1480941]